Moreover, there was no significant change between the AGO and FLX groups, indicating that these two drugs protect similarly against CRS-induced depressive symptoms by interfering with BDNF and TrkB expression and ERK activity in the hippocampus. Here, NTRK2 is linked to congenital rubella syndrome.